Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid LeukemiaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingPhase 32025-01-31NCT06802718

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Peking University People's Hospital269

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Peking University People's HospitalBeijingChina146